CD8A and neoplasm: The combined treatment optimizes the immune system's ability to attack TNBC, improving T cell infiltration and function, and increasing tumor cell apoptosis.[101] Additionally, berberine prolongs allograft survival by inducing apoptosis in alloreactive CD8+ T cells through the mitochondrial apoptosis pathway.